Study on Cost Components of Continuous Ambulatory Peritoneal Dialysis (CAPD) and Hemodialysis (HD) in India

Not Applicable

Completed

• Conditions: Health Condition 1: null- The study is an observational study and will require Early Stage Renal Disease (ESRD) patients who are already on Hemo dialysis or Peritoneal dialysis.

• Registration Number: CTRI/2012/01/002382
• Lead Sponsor: Baxter India Private Limited

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 80

Inclusion Criteria

1. Patients should be between 18-65 years of age

2.Patients should have completed minimum of 3 months on one mode of dialysis

3. Patients who are on HD for at least 10 sessions a month (prevalent practice)

4. Patients undergoing CAPD with at least 3 exchanges per day (prevalent practice)

5. Patients on dextrose based solutions for CAPD

6. Patients shifted from another renal replacement therapy but have completed 3 months on new modality

7. Patient willing to give informed consent

Exclusion Criteria

1. Patients who are on dialysis for less than 3 months

2. Patients on Automated Peritoneal Dialysis

3. Patients using Extraneal as exchange fluid for PD

4. Patients with Hepatitis B & C and HIV infection

5. Patients having Charlson Co-morbidity index 5

6. Patients with mental or neurological disorders, that might make their survey questionable

7. Patients unwilling to cooperate

8. Patients with expected life expectancy less than 1 year

9. Pregnancy and women of child bearing age who are planning for conception in next 12 months (duration of the study)

10. Patients under any reimbursement or health insurance scheme without proper supporting bills

11. Patient expected to be transferred to a non participating center within the period of study

12. Patients who previously have received kidney transplant or intend to receive kidney transplant in next 3 months

13. Patients with concomitant participation in any other interventional study

Study & Design

• Study Type: Observational
• Study Design: Not specified